QSAR, simulation techniques, and ADMET/pharmacokinetics assessment of a set of compounds that target MAO-B as anti-Alzheimer agent
Abstract Background Alzheimer's disease (AD), the most common cause of dementia in the elderly, is a progressive neurodegenerative disorder that gradually affects cognitive function and eventually causes death. Most approved drugs can only treat the disease alleviating the disease symptoms; the...
Saved in:
Main Authors: | Abduljelil Ajala (Author), Adamu Uzairu (Author), Gideon A. Shallangwa (Author), Stephen E. Abechi (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
2D QSAR, design, docking study and ADMET of some N-aryl derivatives concerning inhibitory activity against Alzheimer disease
by: Abduljelil Ajala, et al.
Published: (2022) -
Computational insight to design new potential hepatitis C virus NS5B polymerase inhibitors with drug-likeness and pharmacokinetic ADMET parameters predictions
by: Stephen Ejeh, et al.
Published: (2021) -
2D-QSAR, Docking, Molecular dynamics simulations with the MM/GBSA approaches against Grave's disease and PTPN22
by: Emmanuel Israel Edache, et al.
Published: (2023) -
Computational evaluation of some compounds as potential anti-breast cancer agents
by: Momohjimoh Ovaku Idris, et al.
Published: (2021) -
In silico evaluation of some 4-(quinolin-2-yl)pyrimidin-2-amine derivatives as potent V600E-BRAF inhibitors with pharmacokinetics ADMET and drug-likeness predictions
by: Abdullahi Bello Umar, et al.
Published: (2020)